Clinical Trial Update: Mix Vaccine for Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting Phase 1/2 results for a mixed vaccine in metastatic colorectal cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Mixed vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastatic Colorectal Cancer, Reaction - Mixed Vaccine | Phase 1, Phase 2 | Status: COMPLETED